Kidney, cardiovascular, and metabolic diseases are major contributors to global morbidity and mortality. Research within our theme focuses on deciphering the mechanisms that drive these disorders and exploring how dysfunctional systems interact to accelerate disease progression.
We use a broad range of approaches, including in vivo and in vitro models, state-of-the-art imaging, and omics technologies to advance our understanding of conditions such as hypertension, kidney disease of various etiologies, and metabolic disorders. Our vision is to enhance knowledge on how metabolic, renal, and cardiovascular multisystem disorders impacts mortality.
Our theme hosts more than 25 groups who collaborate with clinicians and the pharmaceutical sector.
The influence of glycerol availability on fat storage in adipose tissue and synthesis of glucose and triglyceride in liver.